An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy.

Rachel J KeoghM MilewskiK BrowneK EganM A HennessyZ CoyneD CowzerA LinehanB T HennessyL GroganP G MorrisO S Breathnach

Published in: Cancer chemotherapy and pharmacology (2021)

Although definitive conclusions are limited by relatively small numbers, it seems unlikely that weekly paclitaxel infusions pose any significant risk to patients driving.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
locally advanced
prognostic factors
peritoneal dialysis
squamous cell carcinoma
radiation therapy
rectal cancer